علاج مرض فيروس شيكونغونيا في المرحلة المزمنة

References

• The clinical management of Chikungunya is based on the phase of the disease.
• The treatment objectives in this phase of illness are to limit the potential joint damage, decrease the functional and psychological impact and improve the quality of life.
• If the response is inadequate after 8–12 weeks, other DMARDs should be considered, including methotrexate, sulfasalazine, and leflunomide.
• Other DMARDs to be considered if the response to hydroxychloroquine is inadequate after 8–12 weeks.